Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events

Coronary Artery Disease

Volumn 23, Issue 1, 2012, Pages 39-44

  Dogan, Abdullah ^a   Icli, Atilla ^a   Aksoy, Fatih ^a   Varol, Ercan ^a   Erdogan, Dogan ^a   Ozaydin, Mehmet ^a   Kocyigit, Sule ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

acute coronary syndromes; cardiac events; gamma glutamyltransferase

Indexed keywords

CREATINE KINASE MB; GAMMA GLUTAMYLTRANSFERASE; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CREATINE KINASE BLOOD LEVEL; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CREATINE KINASE, MB FORM; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TROPONIN T; TURKEY;

EID: 83655184673     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834e4ed0     Document Type: Article

References (25)

1. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28:1598-1660.
2. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010; 13:36-41.
3. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation - a potential mechanism in atherosclerosis. J Investig Med 1999; 47:151-160. (Pubitemid 129541449)
4. Emdin M, Pompella A, Paolicchi A. Gamma glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005; 112:2078-2080. (Pubitemid 41475797)
5. Ruttmann E, Brant LJ, Concin H, Diem G, Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112:2130-2137. (Pubitemid 41475806)
6. Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle aged men and women. Eur Heart J 2006; 27:2170-2176. (Pubitemid 44412830)
7. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007; 27:127-133. (Pubitemid 46360389)
8. Wannamethee SG, Lennon L, Shaper AG. The value of gammaglutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008; 201:168-175.
9. Karlson BW, Wiklund O, Hallgren P, Sjölin M, Lindqvist J, Herlitz J. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000; 247:449-456. (Pubitemid 30253163)
10. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001; 22:1802-1807. (Pubitemid 32929115)
11. Breitling LP, Grandia NC, Hahmannb H, Wüstenc B, Rothenbachera D, Brennera H. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010; 210:649-655.
12. Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U, et al. Serum gamma-glutamyltransferase and mortality in persons undergoing coronary angiography - The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2010; 208:564-571.
13. Emiroglu MY, Esen OB, Bulut M, Karapinar H, Kaya Z, Akcakoyun M, et al. GGT levels in type II diabetic patients with acute coronary syndrome (does diabetes have any effect on GGT levels in acute coronary syndrome?). Acta Diabetol 2010, doi: 10.1007/s00592-010-0208-2.
14. Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, Gulel O. The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009; 32:220-225.
15. Ulus T, Yildirir A, Sade LE, Temiz A, Polat E, Bozbaş H, et al. Serum gammaglutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients? Coron Artery Dis 2008; 19:489-495.
16. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874. (Pubitemid 36019640)
17. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A. Atherosclerotic plaques contain gamma-glutamyl transpeptidase activity. Circulation 2004; 109:1140.
18. Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009; 202:119-127.
19. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF. The prognostic role of gamma-glutamyltransferase activity in non-diabetic STelevation myocardial infarction. Intern Emerg Med 2011; 6:13-19.
20. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007; 50:e1-e157.
21. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284:835-842. (Pubitemid 30643610)
22. Ulus T, Yildirir A, Demirtas S, Demir O, Sade LE, Bozbas H, et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis? Atherosclerosis 2007; 195:348-353. (Pubitemid 350087939)
23. Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358-1366. (Pubitemid 36900623)
24. Lee DH, Jacobs DR Jr. Association between serum gamma glutamyltransferase and C-reactive protein. Atherosclerosis 2005; 178:327-330. (Pubitemid 40193447)
25. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post-discharge death in an international registry. JAMA 2004; 291:2727-2733. (Pubitemid 38725422)